You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
4 May 2020
PreveCeutical Announces Possible Viral Prevention Program Using CBD Sol-gel
23 January 2020
PreveCeutical Retains Patent Legal Team
14 January 2020
PreveCeutical Announces Further Updates to the Successful Engineering & Cell-Based Efficacy Screening of its Smart-siRNA Constructs for its Dual Gene Therapy Research Program
8 January 2020
PreveCeutical Announces Positive Results Following a Preliminary Safety Evaluation of Sol-Gel Formulations When Applied to Human Nasal Tissue
29 October 2019
PreveCeutical Announces Successful Completion from its Design, Synthesis and Preliminary Evaluation of Novel Designed Peptides Derived from Caribbean Blue Scorpion Venom in a Cell-Based Brain Cancer Model
7 October 2019
PreveCeutical Receives $616,802 AUD Research and Development Tax Incentive Cash Refund